← All trials
NCT04886154
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 14, 2021
- Primary completion
- Aug 23, 2023
- Completion date
- Sep 29, 2023
- First posted
- May 13, 2021
- Last posted
- Dec 1, 2021
- Enrollment
- 1258
- Arms / groups
- 11 / —
- Source
- AACT · ingestion pipeline
Sponsors
- GlaxoSmithKlineLead sponsor
- GlaxoSmithKlineStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.